Literature DB >> 10523741

Generalized pustular psoriasis with hypoparathyroidism.

A Kawamura1, M T Kinoshita, H Suzuki.   

Abstract

A 36-year-old Japanese woman with pustular psoriasis associated with hypoparathyroidisum was reported. The patient showed hypocalcemia and was treated with calcium supplements and calcitriol. When the serum calcium level became normal, the pustules disappeared and erythroderma completely resolved. Histopathological features consisted of the formation of intraepidermal pustules including spongiform pustules underneath the stratum corneum, and acantholysis was observed in the epidermis. It was suggested that generalized pustular psoriasis may have been induced by hypocalcemia due to hypoparathyroidism in this case, and that acantholysis may be caused by hypocalcemia, since intercellular junctional components such as cadherins are highly dependent on calcium in the epidermis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523741

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  4 in total

Review 1.  Diagnosis and screening of patients with generalized pustular psoriasis.

Authors:  Karen Ly; Kristen M Beck; Mary P Smith; Quinn Thibodeaux; Tina Bhutani
Journal:  Psoriasis (Auckl)       Date:  2019-06-20

2.  Mucocutaneous manifestations of acquired hypoparathyroidism: An observational study.

Authors:  Somenath Sarkar; Modhuchanda Mondal; Kapildev Das; Arpit Shrimal
Journal:  Indian J Endocrinol Metab       Date:  2012-09

3.  A Case of Acute Generalized Pustular Psoriasis of von Zumbusch Triggered by Hypocalcemia.

Authors:  Carlos Antônio Gusmão Guerreiro de Moura; Luiz Henrique de Assis; Paulo Góes; Fabiana Rosa; Victor Nunes; Ítalo Magalhães Gusmão; Constança Margarida Sampaio Cruz
Journal:  Case Rep Dermatol       Date:  2015-12-03

Review 4.  Diagnosis of Generalized Pustular Psoriasis.

Authors:  Hideki Fujita; Melinda Gooderham; Ricardo Romiti
Journal:  Am J Clin Dermatol       Date:  2022-01-21       Impact factor: 7.403

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.